Natan Ponieman - Spark Newswire

2 minute read

California Approves $100M Boost To Help Regulate Struggling Cannabis Industry

Today, 4:50 PM

California is injecting $100 million into the state's struggling legal cannabis industry. A new measure, proposed by Gov. Gavin Newsom, was approved by the California Legislature on Monday and aims to help legal cannabis operators acquire permanent licenses.

CSE:HBOR

4 minute read

Psyched: Atai’s $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers

By Natan Ponieman

Today, 4:50 PM

Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial public offering of approximately 14 million of its common shares, ahead of the company’s expected Nasdaq listing.

CLXPF

2 minute read

Red Light Holland Buys Virtual Reality Company And Majority Stake In Grow-At-Home Mushroom Company

By Natan Ponieman

Today, 4:50 PM

Red Light Holland Corp. (Canadian: TRIP) (OTC Pink: TRUFF), a company looking at recreational markets in the psychedelics space, closed two major acquisitions this week.

TRUFF

1 minute read

Global Trac Solutions Reports Record Pageviews Of Psychedelics Industry Indicate An Expanding Interest In The Sector

By Natan Ponieman

Today, 4:50 PM

Global Trac Solutions, Inc. (OTCPink: PSYC), a digital media company focused on the psychedelics sector, published traffic results for its Psychedelic Spotlight news platform.

PSYC

3 minute read

22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics

By Natan Ponieman

Today, 4:50 PM

22nd Century Group, Inc. (NYSE: XXII) is a plant biotechnology company covering the tobacco, hemp and cannabis markets.

ACB

4 minute read

Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility

By Natan Ponieman

Today, 4:50 PM

The Nasdaq welcomed its third psychedelics company this week, with the acquisition of MagicMed Industries by Enveric Biosciences (NASDAQ:

CSE:DELC

4 minute read

Meet PsyBio, A Company Producing Psilocybin From Genetically-Modified Bacteria

By Natan Ponieman

Today, 4:50 PM

As psychedelics draw closer to legalization, companies in the industry have yet to figure out the most efficient and cost-effective way of producing psilocybin and other molecules on a commercial scale.

CMPS

4 minute read

Uncategorized

Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M

By Natan Ponieman

Today, 4:50 PM

Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound.

CLABF

4 minute read

Uncategorized

World’s First Phase 3 Clinical Trial On MDMA Shows ‘Powerful New Pathway To Healing’

By Natan Ponieman

Today, 4:50 PM

The results from the world’s first Phase 3 clinical study on a psychedelic are in — and they’re significant. The Multidisciplinary Association for Psychedelic Studies released the results from its Phase 3 trial on MDMA for the treatment of post-traumatic stress disorder.

2 minute read

Uncategorized

Mydecine Posts $26.9M Net Loss For 2020: What’s Ahead For Psychedelic Stock

By Natan Ponieman

Today, 4:50 PM

Denver-based Mydecine Innovations Group (NEO: MYCO) (Pink: MYCOF) released its 2020 yearly financial results this week, ending the year with $2.2 million in cash. The company reported having raised over $30 million more since the beginning of 2021.

MYCOF